- Home
- DERM vs STIM Comparison
DERM vs STIM Comparison
Compare DERM & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- STIM
- Stock Information
- Founded
- DERM 2014
- STIM 2003
- Country
- DERM United States
- STIM United States
- Employees
- DERM N/A
- STIM N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- DERM Health Care
- STIM Health Care
- Exchange
- DERM Nasdaq
- STIM Nasdaq
- Market Cap
- DERM 190.7M
- STIM 224.8M
- IPO Year
- DERM 2021
- STIM 2018
- Fundamental
- Price
- DERM $7.54
- STIM $2.90
- Analyst Decision
- DERM Strong Buy
- STIM Strong Buy
- Analyst Count
- DERM 3
- STIM 2
- Target Price
- DERM $12.67
- STIM $7.00
- AVG Volume (30 Days)
- DERM 92.2K
- STIM 1.2M
- Earning Date
- DERM 11-11-2025
- STIM 11-11-2025
- Dividend Yield
- DERM N/A
- STIM N/A
- EPS Growth
- DERM N/A
- STIM N/A
- EPS
- DERM N/A
- STIM N/A
- Revenue
- DERM $56,397,000.00
- STIM $111,106,000.00
- Revenue This Year
- DERM $26.25
- STIM $105.70
- Revenue Next Year
- DERM $52.96
- STIM $11.77
- P/E Ratio
- DERM N/A
- STIM N/A
- Revenue Growth
- DERM N/A
- STIM 54.17
- 52 Week Low
- DERM $3.54
- STIM $0.52
- 52 Week High
- DERM $8.90
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- DERM 59.93
- STIM 47.33
- Support Level
- DERM $6.85
- STIM $2.58
- Resistance Level
- DERM $7.45
- STIM $3.01
- Average True Range (ATR)
- DERM 0.30
- STIM 0.18
- MACD
- DERM 0.04
- STIM 0.04
- Stochastic Oscillator
- DERM 100.00
- STIM 78.16
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.